Integra LifeSciences | IART - Selling And Administration Expenses

Stock Price
10.57
Daily Change
0.25 2.42%
Monthly
10.68%
Yearly
-37.12%
Q2 Forecast
10.34

Integra LifeSciences reported $156.45M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
AtriCure USD 78.34M 109K Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
CONMED USD 166.76M 26.42M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Globus Medical USD 318.48M 4.88M Dec/2025
HeartBeam USD 1.18M 96.62K Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025